Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes

NCT01940965 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: lixisenatide AVE0010
DRUG: biguanide
DRUG: TZD
DRUG: alpha-GI
DRUG: glinide

Sponsor

Sanofi